Click for best price
Gene Therapies for Cancer Treatment Market Size, Share 2023
In the medicine field, gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
This report aims to provide a comprehensive presentation of the global market for Gene Therapies for Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapies for Cancer Treatment. This report contains market size and forecasts of Gene Therapies for Cancer Treatment in global, including the following market information:
Global Gene Therapies for Cancer Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gene Therapies for Cancer Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Somatic Cell Gene Therapy (SCGT) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gene Therapies for Cancer Treatment include Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, Momotaro-Gene, MultiVir, SynerGene Therapeutics and Ziopharm Oncology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Therapies for Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapies for Cancer Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gene Therapies for Cancer Treatment Market Segment Percentages, by Type, 2022 (%)
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Global Gene Therapies for Cancer Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gene Therapies for Cancer Treatment Market Segment Percentages, by Application, 2022 (%)
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
Global Gene Therapies for Cancer Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gene Therapies for Cancer Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapies for Cancer Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Therapies for Cancer Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celgene
Celsion
Bluebird Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Therapies for Cancer Treatment, market overview.
Chapter 2: Global Gene Therapies for Cancer Treatment market size in revenue.
Chapter 3: Detailed analysis of Gene Therapies for Cancer Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Therapies for Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Gene Therapies for Cancer Treatment Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene Therapies for Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapies for Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapies for Cancer Treatment Overall Market Size
2.1 Global Gene Therapies for Cancer Treatment Market Size: 2022 VS 2029
2.2 Global Gene Therapies for Cancer Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapies for Cancer Treatment Players in Global Market
3.2 Top Global Gene Therapies for Cancer Treatment Companies Ranked by Revenue
3.3 Global Gene Therapies for Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapies for Cancer Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene Therapies for Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapies for Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapies for Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapies for Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapies for Cancer Treatment Market Size Markets, 2022 & 2029
4.1.2 Somatic Cell Gene Therapy (SCGT)
4.1.3 Germline Gene Therapy (GGT)
4.2 By Type - Global Gene Therapies for Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Gene Therapies for Cancer Treatment Revenue, 2018-2023
4.2.2 By Type - Global Gene Therapies for Cancer Treatment Revenue, 2024-2029
4.2.3 By Type - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapies for Cancer Treatment Market Size, 2022 & 2029
5.1.2 Cancer Research Centers
5.1.3 Diagnostic Laboratories
5.1.4 Cancer Hospitals
5.1.5 Others
5.2 By Application - Global Gene Therapies for Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Gene Therapies for Cancer Treatment Revenue, 2018-2023
5.2.2 By Application - Global Gene Therapies for Cancer Treatment Revenue, 2024-2029
5.2.3 By Application - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gene Therapies for Cancer Treatment Market Size, 2022 & 2029
6.2 By Region - Global Gene Therapies for Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Gene Therapies for Cancer Treatment Revenue, 2018-2023
6.2.2 By Region - Global Gene Therapies for Cancer Treatment Revenue, 2024-2029
6.2.3 By Region - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gene Therapies for Cancer Treatment Revenue, 2018-2029
6.3.2 US Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.3.3 Canada Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.3.4 Mexico Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gene Therapies for Cancer Treatment Revenue, 2018-2029
6.4.2 Germany Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.4.3 France Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.4.4 U.K. Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.4.5 Italy Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.4.6 Russia Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.4.8 Benelux Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gene Therapies for Cancer Treatment Revenue, 2018-2029
6.5.2 China Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.5.3 Japan Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.5.4 South Korea Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.5.6 India Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gene Therapies for Cancer Treatment Revenue, 2018-2029
6.6.2 Brazil Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.6.3 Argentina Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapies for Cancer Treatment Revenue, 2018-2029
6.7.2 Turkey Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.7.3 Israel Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Gene Therapies for Cancer Treatment Market Size, 2018-2029
6.7.5 UAE Gene Therapies for Cancer Treatment Market Size, 2018-2029
7 Gene Therapies for Cancer Treatment Companies Profiles
7.1 Takara Bio
7.1.1 Takara Bio Company Summary
7.1.2 Takara Bio Business Overview
7.1.3 Takara Bio Gene Therapies for Cancer Treatment Major Product Offerings
7.1.4 Takara Bio Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.1.5 Takara Bio Key News & Latest Developments
7.2 Tocagen
7.2.1 Tocagen Company Summary
7.2.2 Tocagen Business Overview
7.2.3 Tocagen Gene Therapies for Cancer Treatment Major Product Offerings
7.2.4 Tocagen Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.2.5 Tocagen Key News & Latest Developments
7.3 VBL Therapeutics
7.3.1 VBL Therapeutics Company Summary
7.3.2 VBL Therapeutics Business Overview
7.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Major Product Offerings
7.3.4 VBL Therapeutics Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.3.5 VBL Therapeutics Key News & Latest Developments
7.4 Cold Genesys
7.4.1 Cold Genesys Company Summary
7.4.2 Cold Genesys Business Overview
7.4.3 Cold Genesys Gene Therapies for Cancer Treatment Major Product Offerings
7.4.4 Cold Genesys Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.4.5 Cold Genesys Key News & Latest Developments
7.5 Genprex
7.5.1 Genprex Company Summary
7.5.2 Genprex Business Overview
7.5.3 Genprex Gene Therapies for Cancer Treatment Major Product Offerings
7.5.4 Genprex Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.5.5 Genprex Key News & Latest Developments
7.6 Momotaro-Gene
7.6.1 Momotaro-Gene Company Summary
7.6.2 Momotaro-Gene Business Overview
7.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Major Product Offerings
7.6.4 Momotaro-Gene Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.6.5 Momotaro-Gene Key News & Latest Developments
7.7 MultiVir
7.7.1 MultiVir Company Summary
7.7.2 MultiVir Business Overview
7.7.3 MultiVir Gene Therapies for Cancer Treatment Major Product Offerings
7.7.4 MultiVir Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.7.5 MultiVir Key News & Latest Developments
7.8 SynerGene Therapeutics
7.8.1 SynerGene Therapeutics Company Summary
7.8.2 SynerGene Therapeutics Business Overview
7.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Major Product Offerings
7.8.4 SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.8.5 SynerGene Therapeutics Key News & Latest Developments
7.9 Ziopharm Oncology
7.9.1 Ziopharm Oncology Company Summary
7.9.2 Ziopharm Oncology Business Overview
7.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Major Product Offerings
7.9.4 Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.9.5 Ziopharm Oncology Key News & Latest Developments
7.10 Anchiano Therapeutics
7.10.1 Anchiano Therapeutics Company Summary
7.10.2 Anchiano Therapeutics Business Overview
7.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Major Product Offerings
7.10.4 Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.10.5 Anchiano Therapeutics Key News & Latest Developments
7.11 Celgene
7.11.1 Celgene Company Summary
7.11.2 Celgene Business Overview
7.11.3 Celgene Gene Therapies for Cancer Treatment Major Product Offerings
7.11.4 Celgene Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.11.5 Celgene Key News & Latest Developments
7.12 Celsion
7.12.1 Celsion Company Summary
7.12.2 Celsion Business Overview
7.12.3 Celsion Gene Therapies for Cancer Treatment Major Product Offerings
7.12.4 Celsion Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.12.5 Celsion Key News & Latest Developments
7.13 Bluebird Bio
7.13.1 Bluebird Bio Company Summary
7.13.2 Bluebird Bio Business Overview
7.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Major Product Offerings
7.13.4 Bluebird Bio Gene Therapies for Cancer Treatment Revenue in Global Market (2018-2023)
7.13.5 Bluebird Bio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gene Therapies for Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Gene Therapies for Cancer Treatment Market Drivers in Global Market
Table 3. Gene Therapies for Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Gene Therapies for Cancer Treatment in Global Market
Table 5. Top Gene Therapies for Cancer Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene Therapies for Cancer Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene Therapies for Cancer Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene Therapies for Cancer Treatment Product Type
Table 9. List of Global Tier 1 Gene Therapies for Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapies for Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gene Therapies for Cancer Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene Therapies for Cancer Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gene Therapies for Cancer Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene Therapies for Cancer Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gene Therapies for Cancer Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene Therapies for Cancer Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Takara Bio Company Summary
Table 31. Takara Bio Gene Therapies for Cancer Treatment Product Offerings
Table 32. Takara Bio Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Takara Bio Key News & Latest Developments
Table 34. Tocagen Company Summary
Table 35. Tocagen Gene Therapies for Cancer Treatment Product Offerings
Table 36. Tocagen Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Tocagen Key News & Latest Developments
Table 38. VBL Therapeutics Company Summary
Table 39. VBL Therapeutics Gene Therapies for Cancer Treatment Product Offerings
Table 40. VBL Therapeutics Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. VBL Therapeutics Key News & Latest Developments
Table 42. Cold Genesys Company Summary
Table 43. Cold Genesys Gene Therapies for Cancer Treatment Product Offerings
Table 44. Cold Genesys Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Cold Genesys Key News & Latest Developments
Table 46. Genprex Company Summary
Table 47. Genprex Gene Therapies for Cancer Treatment Product Offerings
Table 48. Genprex Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Genprex Key News & Latest Developments
Table 50. Momotaro-Gene Company Summary
Table 51. Momotaro-Gene Gene Therapies for Cancer Treatment Product Offerings
Table 52. Momotaro-Gene Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Momotaro-Gene Key News & Latest Developments
Table 54. MultiVir Company Summary
Table 55. MultiVir Gene Therapies for Cancer Treatment Product Offerings
Table 56. MultiVir Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. MultiVir Key News & Latest Developments
Table 58. SynerGene Therapeutics Company Summary
Table 59. SynerGene Therapeutics Gene Therapies for Cancer Treatment Product Offerings
Table 60. SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. SynerGene Therapeutics Key News & Latest Developments
Table 62. Ziopharm Oncology Company Summary
Table 63. Ziopharm Oncology Gene Therapies for Cancer Treatment Product Offerings
Table 64. Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Ziopharm Oncology Key News & Latest Developments
Table 66. Anchiano Therapeutics Company Summary
Table 67. Anchiano Therapeutics Gene Therapies for Cancer Treatment Product Offerings
Table 68. Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Anchiano Therapeutics Key News & Latest Developments
Table 70. Celgene Company Summary
Table 71. Celgene Gene Therapies for Cancer Treatment Product Offerings
Table 72. Celgene Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Celgene Key News & Latest Developments
Table 74. Celsion Company Summary
Table 75. Celsion Gene Therapies for Cancer Treatment Product Offerings
Table 76. Celsion Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Celsion Key News & Latest Developments
Table 78. Bluebird Bio Company Summary
Table 79. Bluebird Bio Gene Therapies for Cancer Treatment Product Offerings
Table 80. Bluebird Bio Gene Therapies for Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. Bluebird Bio Key News & Latest Developments
List of Figures
Figure 1. Gene Therapies for Cancer Treatment Segment by Type in 2022
Figure 2. Gene Therapies for Cancer Treatment Segment by Application in 2022
Figure 3. Global Gene Therapies for Cancer Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Therapies for Cancer Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gene Therapies for Cancer Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2022
Figure 8. By Type - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
Figure 16. US Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
Figure 28. China Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gene Therapies for Cancer Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gene Therapies for Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Takara Bio Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Tocagen Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. VBL Therapeutics Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cold Genesys Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Genprex Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Momotaro-Gene Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. MultiVir Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Celgene Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Celsion Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Bluebird Bio Gene Therapies for Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
